Subscribe
Wednesday, March 25, 2026
25.9 C
Bengaluru
type here...
Subscribe

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Biologics Anup Soans -
Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as the world's first biosimilar of...
Biologics

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

0
Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...
Exclusive Articles

Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled

0
From Gas Cylinders to ICU Beds: How the Gulf...
Exclusive Articles

Gila Monster Venom: The Unexpected Spark of the GLP-1 Revolution

0
In the blistering Sonoran Desert, where temperatures regularly exceed...
Exclusive Articles

The Quiet Crisis in the Indian Pharma Field Force

0
A MedicinMan Editorial based on the Poll framed by...
Exclusive Report

The West Plays Precision Poker with High-stakes Specialty Drugs while India Plays Volume Chess with Portfolio Resilience

0
A recent industry spotlight by Venkat Mutavi notes a...
Indian Pharma Market Reports

IPM Powers Ahead in 2026: 11% Growth Fueled by Cardiac, Anti-Diabetics, and GLP-1 Stars

0
India's pharmaceutical market charged into 2026 with strong momentum,...
Healthcare News

How Smart Medical Reps Can Beat Bots

0
Today's Brand Equity cover — a woman lost in...
Exclusive Report

Nutraceuticals: Health, Hope Or Hype?

0
Walk into almost any clinic today and you will...

Topics

Don't Miss MedicinMan Updates

Hot this week

AI in Healthcare

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

0
1. Market Overview The oncology sector remains the most dominant...
AI in Healthcare

Blinkit, Zepto, Instamart: Who Will Own India’s At‑Home Diagnostics Market?

0
India’s diagnostics market is undergoing a quiet but profound...
spot_img

Follow Us

Popular Categories

Featured Article84Healthcare News50Exclusive Articles47Leaderspeak47Special Issue45Thought Leadership20

Video Insights

spot_imgspot_img

Headlines

Gila Monster Venom: The Unexpected Spark of the GLP-1 Revolution

Exclusive Articles Anup Soans -
In the blistering Sonoran Desert, where temperatures regularly exceed 100 degrees Fahrenheit, a sluggish, beaded lizard emerges from its...

The Uncomfortable Truth about Indian Generics: Untangling the Conundrum

Exclusive Articles Anup Soans -
India’s pharmaceutical industry occupies a unique and powerful position in global healthcare. It supplies nearly half of all generic...

Exclusive Articles

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as the world's first biosimilar of ranibizumab, it promised to transform...

Music

The West Plays Precision Poker with High-stakes Specialty Drugs while India Plays Volume Chess with Portfolio Resilience

0
A recent industry spotlight by Venkat Mutavi notes a...

IPM Powers Ahead in 2026: 11% Growth Fueled by Cardiac, Anti-Diabetics, and GLP-1 Stars

0
India's pharmaceutical market charged into 2026 with strong momentum,...

How Smart Medical Reps Can Beat Bots

0
Today's Brand Equity cover — a woman lost in...

Nutraceuticals: Health, Hope Or Hype?

0
Walk into almost any clinic today and you will...

Food

How Smart Medical Reps Can Beat Bots

0
Today's Brand Equity cover — a woman lost in...

Nutraceuticals: Health, Hope Or Hype?

0
Walk into almost any clinic today and you will...

When Biology Beats Willpower: The Rise of GLP‑1/GIP Therapies

0
“Lifestyle advice often asks patients to fight powerful evolutionary...

The Antifungal Blind Spot: India’s Quiet Clinical Crisis

0
A market analysis and clinical commentary on the growing...

Samuel Paradise

Manuela Cole

Keisha Adams

George Pharell

spot_imgspot_img

Leaders Speak

Business leaders sharing their insights

Salil Kallianpur
Salil Kallianpur
14 POSTS
http://salilkallianpur.wordpress.com
K. Hariram
K. Hariram
8 POSTS
Deep Bhandari
Deep Bhandari
6 POSTS
Amaninder Dhillon
Amaninder Dhillon
6 POSTS
Raja Reddy
Raja Reddy
5 POSTS
Noumaan Qureshi
Noumaan Qureshi
5 POSTS
Arun Subramanian
Arun Subramanian
3 POSTS
https://www.enparadigm.com/
View More

MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More

Company

Headlines

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

0
Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled

0
From Gas Cylinders to ICU Beds: How the Gulf...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

0
As over 50 generic versions of the blockbuster weight-loss...

Excellence or Mediocrity—What Are You Building?

0
Excellence is a choice. So is Mediocrity Excellence is a...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 | Crafted by SlamDunk